Michelson Medical Research Foundation Inc. grew its holdings in shares of Rentokil Initial PLC (NYSE:RTO - Free Report) by 177.8% in the 1st quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor owned 500,000 shares of the company's stock after purchasing an additional 320,000 shares during the period. Rentokil Initial makes up 9.2% of Michelson Medical Research Foundation Inc.'s portfolio, making the stock its 3rd biggest holding. Michelson Medical Research Foundation Inc. owned 0.10% of Rentokil Initial worth $11,450,000 as of its most recent SEC filing.
Several other large investors also recently made changes to their positions in the business. Gates Capital Management Inc. boosted its position in shares of Rentokil Initial by 5.7% during the 1st quarter. Gates Capital Management Inc. now owns 6,615,305 shares of the company's stock valued at $151,490,000 after purchasing an additional 357,292 shares in the last quarter. Voss Capital LP boosted its holdings in shares of Rentokil Initial by 12.4% in the first quarter. Voss Capital LP now owns 3,471,946 shares of the company's stock worth $79,508,000 after buying an additional 381,659 shares during the period. Alberta Investment Management Corp boosted its holdings in shares of Rentokil Initial by 36.8% in the first quarter. Alberta Investment Management Corp now owns 1,794,900 shares of the company's stock worth $41,103,000 after buying an additional 482,429 shares during the period. Sunriver Management LLC acquired a new position in shares of Rentokil Initial in the first quarter worth about $21,864,000. Finally, Maverick Capital Ltd. boosted its holdings in shares of Rentokil Initial by 5.0% during the first quarter. Maverick Capital Ltd. now owns 870,105 shares of the company's stock worth $19,925,000 after purchasing an additional 41,294 shares during the period. Institutional investors own 9.91% of the company's stock.
Rentokil Initial Stock Performance
RTO stock traded up $0.71 on Thursday, reaching $25.17. 838,833 shares of the company were exchanged, compared to its average volume of 811,867. The firm has a market capitalization of $12.71 billion, a PE ratio of 16.67, a PEG ratio of 4.30 and a beta of 0.94. The company has a debt-to-equity ratio of 0.59, a current ratio of 0.81 and a quick ratio of 0.72. The stock's fifty day moving average price is $24.16 and its 200 day moving average price is $23.57. Rentokil Initial PLC has a 12 month low of $19.60 and a 12 month high of $31.74.
Rentokil Initial Cuts Dividend
The business also recently declared a semi-annual dividend, which will be paid on Tuesday, September 23rd. Stockholders of record on Friday, August 15th will be paid a $0.2738 dividend. The ex-dividend date of this dividend is Friday, August 15th. This represents a dividend yield of 240.0%. Rentokil Initial's dividend payout ratio is 29.80%.
Analyst Ratings Changes
Several research firms recently commented on RTO. Deutsche Bank Aktiengesellschaft restated a "buy" rating on shares of Rentokil Initial in a report on Monday, July 21st. Sanford C. Bernstein cut shares of Rentokil Initial from a "market perform" rating to an "underperform" rating in a report on Thursday, May 15th. One analyst has rated the stock with a Strong Buy rating, one has assigned a Buy rating, one has issued a Hold rating and one has issued a Sell rating to the company's stock. According to data from MarketBeat, the stock currently has a consensus rating of "Moderate Buy".
Check Out Our Latest Report on Rentokil Initial
Rentokil Initial Profile
(
Free Report)
Rentokil Initial plc, together with its subsidiaries, provides route-based services in North America, the United Kingdom, rest of Europe, Asia, the Pacific, and internationally. It offers a range of pest control services for rodents, and flying and crawling insects, as well as other forms of wildlife management for commercial customers.
Read More
Before you consider Rentokil Initial, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Rentokil Initial wasn't on the list.
While Rentokil Initial currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Enter your email address and we'll send you MarketBeat's list of ten stocks that are set to soar in Fall 2025, despite the threat of tariffs and other economic uncertainty. These ten stocks are incredibly resilient and are likely to thrive in any economic environment.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
